These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 9407498

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Troglitazone halts diabetic glomerulosclerosis by blockade of mesangial expansion.
    McCarthy KJ, Routh RE, Shaw W, Walsh K, Welbourne TC, Johnson JH.
    Kidney Int; 2000 Dec; 58(6):2341-50. PubMed ID: 11115068
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Metabolic abnormalities in the genetically obese and diabetic Otsuka Long-Evans Tokushima Fatty rat can be prevented and reversed by alpha-glucosidase inhibitor.
    Yamamoto M, Jia DM, Fukumitsu KI, Imoto I, Kihara Y, Hirohata Y, Otsuki M.
    Metabolism; 1999 Mar; 48(3):347-54. PubMed ID: 10094112
    [Abstract] [Full Text] [Related]

  • 6. Reduction of carbohydrate-induced hypertriglyceridemia in (fa,fa) "Zucker" rats by the alpha-glucosidase inhibitor acarbose (BAY g 5421).
    Krause HP, Keup U, Thomas G, Puls W.
    Metabolism; 1982 Jul; 31(7):710-4. PubMed ID: 7045575
    [Abstract] [Full Text] [Related]

  • 7. Effects of a glucosidase inhibitor (acarbose, BAY g 5421) on the development of obesity and food motivated behavior in Zucker (fafa) rats.
    Vasselli JR, Haraczkiewicz E, Maggio CA, Greenwood MR.
    Pharmacol Biochem Behav; 1983 Jul; 19(1):85-95. PubMed ID: 6622510
    [Abstract] [Full Text] [Related]

  • 8. Hyperinsulinemia and smooth muscle cell proliferation.
    Ridray S.
    Int J Obes Relat Metab Disord; 1995 May; 19 Suppl 1():S39-51. PubMed ID: 7550537
    [Abstract] [Full Text] [Related]

  • 9. Acarbose treatment and diabetic nephropathy in the Cohen diabetic rat.
    Cohen AM, Rosenmann E.
    Horm Metab Res; 1990 Oct; 22(10):511-5. PubMed ID: 2079312
    [Abstract] [Full Text] [Related]

  • 10. Early acarbose treatment ameliorates resistance of insulin-regulated GLUT4 trafficking in obese Zucker rats.
    Ledwig D, Müller H, Bischoff H, Eckel J.
    Eur J Pharmacol; 2002 Jun 07; 445(1-2):141-8. PubMed ID: 12065205
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of insulin and acarbose alone and in combination in the female streptozotocin-induced diabetic rat.
    Katovich MJ, Meldrum MJ.
    J Pharm Sci; 1993 Dec 07; 82(12):1209-13. PubMed ID: 8308697
    [Abstract] [Full Text] [Related]

  • 15. YM440, a novel hypoglycemic agent, protects against nephropathy in Zucker fatty rats via plasma triglyceride reduction.
    Nakano R, Kurosaki E, Shimaya A, Kajikawa S, Shibasaki M.
    Eur J Pharmacol; 2006 Nov 07; 549(1-3):185-91. PubMed ID: 16989806
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes.
    Coimbra TM, Janssen U, Gröne HJ, Ostendorf T, Kunter U, Schmidt H, Brabant G, Floege J.
    Kidney Int; 2000 Jan 07; 57(1):167-82. PubMed ID: 10620198
    [Abstract] [Full Text] [Related]

  • 20. Prevention of obesity-linked renal disease: age-dependent effects of dietary food restriction.
    Maddox DA, Alavi FK, Santella RN, Zawada ET.
    Kidney Int; 2002 Jul 07; 62(1):208-19. PubMed ID: 12081580
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.